. We have authorized share capital of 507,043,147.29 in line with the requirement by the National Health Insurance Scheme. At Synergy... / understanding and avail you the best services. We partner with over 3,500 providers accredited by the National Health Insurance...
changes. MUST HAVE EXPERIENCE: Experience working in a FinTech, insurance or financial institution Strong business... insurance benefits. We Seek Collaborative Builders: At Cellulant, we believe that great ideas happen when we come together...
Chandan Taparia has recommended three stocks to buy tomorrow, July 9. According to him, these stocks – BHEL, Chambal Fertilizers, GAIL– are technically placed to see a decent upmove. Continue Reading »
The National Stock Exchange last week imposed a price control cap of 90% over the issue price for SME IPOs. The rule means that the listing-day gain can't be more than 90% of the issue price. Some industry experts believe it will discourage speculation, while others worry it could hurt valuations. Continue Reading »
In an exchange filing, the company announced that its board has approved an interim dividend of ₹2.75 per share with a face value of ₹1 each for the financial year 2024-25. Continue Reading »
Hitachi Energy India's stock has soared by 235% since October 2023, reaching new highs. The company's growth is fueled by factors like grid digitalisation, increased power generation, and a strong demand for transmission equipment. Continue Reading »
Stock Market today: Bajaj Auto, Hero MotoCorp , Eicher Motors, TVS Motor share prices have risen 49-74% over last year. While the two wheeler sales in FY24 grew strong 9.8%, CareEdge Ratings expects 7-9% FY25 growth led by EV Sales, rural demand picks up, new models lainches and other reasons . Continue Reading »
Sati Poly Plast IPO subscription starts on July 12 and ends on July 16 with a price band of ₹123 to ₹130 per share. Company offers flexible packaging solutions for various sectors. Top 10 customers contribute more than 50% of revenue. Continue Reading »
The Nifty Pharma index has outperformed the benchmark Nifty 50, rising nearly 48 per cent. The benchmark index has gained nearly 26 per cent in the same period. Continue Reading »